Ragifilimab (anti-TNFRSF18) - Primary antibody, specific to TNFRSF18, >95%, high purity, Human IgG1, AGONIST of Tumor necrosis factor receptor superfamily member 18 agonist
Ragifilimab (anti-TNFRSF18) - Primary antibody, specific to TNFRSF18, >95%, high purity, Human IgG1, AGONIST of Tumor necrosis factor receptor superfamily member 18 agonist
AGONIST of Tumor necrosis factor receptor superfamily member 18 agonist
Product Description
Ragifilimab (anti-TNFRSF18) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab (anti-TNFRSF18) can be used for advanced or metastatic solid tumors research. Purity >95% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg
Product Properties
Isotype
Human IgG1
Light Chain Type
kappa
SDS-PAGE
27.8 kDa (Light Chain) & 51.5 kDa (Heavy Chain), under reducing conditions; 176.3 kDa, under non-reducing conditions.
Purification Method
Protein A purified
Purity
>95%
Form
Liquid
Concentration
Lot by Lot
Storage Temp
Store at -80°C,Avoid repeated freezing and thawing
Shipped In
Ice chest + Ice pads
Stability And Storage
Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS
2207590-51-8
Images
Ragifilimab (anti-TNFRSF18) (Ab176088) - Flow Cytometry Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood lymphocytes labelling TNFRSF18 with Ragifilimab (anti-TNFRSF18) (Ab176088) conjugated with biotin (right panel) compared with Human IgG (Ab170213) conjugated with biotin - Isotype Control (left panel) and detected with SA-PE (rp156250).
Ragifilimab (anti-TNFRSF18) (Ab176088) - Flow Cytometry Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood lymphocytes labelling TNFRSF18 (red) with Ragifilimab (anti-TNFRSF18) (Ab176088) conjugated with biotin and detected with SA-PE (rp156250). Blue - Isotype control, human IgG (Ab170213) conjugated with biotin. Black - Unlabelled control, cells without incubation with primary antibody.
Ragifilimab (anti-TNFRSF18) (Ab176088) - SEC The purity of Ragifilimab (anti-TNFRSF18) (Ab176088) is more than 95% verified by HPLC.
Associated Targets
TNFRSF18Tbio Tumor necrosis factor receptor superfamily member 18 0 Activities
1.Kwon, B B and 9 more authors.. (1999) Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand.. The Journal of biological chemistry, (5):[PMID:10037686]
2.Gurney, A L AL and 15 more authors.. (1999) Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR.. Current biology : CB, (25):[PMID:10074428]
3.Nocentini, G G and 7 more authors.. (2000) Identification of three novel mRNA splice variants of GITR.. Cell death and differentiation, [PMID:10836847]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.